CDXS - CODEXIS, INC.

1.58
-0.080   -5.063%

Share volume: 994,650
Last Updated: 03-27-2026
Chemicals/Industrial Organic Chemicals: 0.10%

PREVIOUS CLOSE
CHG
CHG%
$1.66
-0.08
-0.05%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
20%
Profitability 8%
Dept financing 12%
Liquidity 75%
Performance 20%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-1.86%
1 Month
54.90%
3 Months
-3.66%
6 Months
-35.90%
1 Year
-43.77%
2 Year
-54.73%
Key data
Stock price
$1.58
P/E Ratio 
0.00
DAY RANGE
$1.56 - $1.64
EPS 
-$0.75
52 WEEK RANGE
$0.96 - $3.87
52 WEEK CHANGE
-$41.26
MARKET CAP 
220.212 M
YIELD 
N/A
SHARES OUTSTANDING 
90.324 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-01-2025
BETA 
2.04
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$1,485,567
AVERAGE 30 VOLUME 
$4,212,803
Company detail
CEO: Stephen G. Dilly
Region: US
Website: codexis.com
Employees: 250
IPO year: 2010
Issue type: Common Stock
Market: XNAS
Industry: Chemicals/Industrial Organic Chemicals
Sector: Manufacturing

Codexis, Inc. discovers, develops, and sells enzymes and other proteins. The company also provides biocatalyst screening and protein engineering services. It sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe.

Recent news